KOBE Biomedical Innovation Cluster newsletter vol. 58
- April 2025 -
vol. 58 April 2025
Hello,
Kobe Biomedical Innovation Cluster (KBIC) had exhibited as “KBIC” booth at Medtec Japan held at Tokyo Big Sight from April 9th through April 11th. KBIC co-exhibited with 6 companies from Kobe together with Kobe University. We’ve got good traffic of visitors!!
Also in-booth company pitch was held every day and many companies from Kobe introduced their products, technologies and services.
It is always a valuable opportunity for us to connect with companies and organizations from both Japan and overseas. We look forward to seeing you again at the next exhibition!
If you missed our past issues of KBIC newsletter, please visit Newsletter Archive.
FBRI Editorial Team
NEWS
MiCAN Establishes German Subsidiary for MylcMAT Deployment
MiCAN Technologies, Inc. (Headquarters: Kyoto, Japan; President: Kazuo Miyazaki) has established a subsidiary in Heidelberg, Germany. MiCAN Technologies EUROPA GmbH has started to offer a new thermogenic test product (MylcMAT®) for the European market, using immortalized monocyte cells (aMylc), which is a regenerative medicine technology.
Synplogen has entered into a business alliance agreement with ARCALIS, Inc. to promote development and manufacturing of mRNA therapeutics and vaccines
Synplogen Co., Ltd. (Head Office: Chuo-ku, Kobe; hereinafter referred to as “Synplogen”) and ARCALIS, Inc. (Head Office: Minamisoma, Fukushima; hereinafter referred to as “ARCALIS”) have concluded a business alliance agreement to advance the development and manufacturing of mRNA therapeutics and vaccines by maximizing each other's technologies, knowledge, and resources.
Grow Your Medical Business in Kobe!
We help international medical business thrive in Japan with world-class research institutes and facilities.
Visit KBIC Website!
We help international medical business thrive in Japan with world-class research institutes and facilities.
Follow us on LinkedIn!
Newsletter Archive